PUBLISHER: The Business Research Company | PRODUCT CODE: 1947006
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947006
An absorbable powder hemostat is a sterile, bioresorbable material designed to control bleeding during surgical procedures. Made from polysaccharides derived from plants or animals, it quickly absorbs blood and facilitates clot formation. Its powdered form enables easy application to uneven or hard-to-reach areas in surgery. The main purpose of this product is to achieve rapid hemostasis and reduce the risks associated with bleeding during surgery.
The primary categories of absorbable powder hemostats include collagen-based, gelatin-based, cellulose-based, and combination types. Collagen-based powders, sourced from bovine or porcine tissues, help accelerate clotting by activating platelets and are commonly used for effective bleeding control in surgeries. These hemostats come in various forms, including powders, ready-to-use mixes, pre-mixed, and custom formulations, and are distributed through multiple channels such as direct sales, distributors, online platforms, and pharmacies. They are applied in diverse medical fields like surgical procedures, trauma care, orthopedic operations, and cardiovascular surgeries, and are utilized by a range of end-users including hospitals, ambulatory surgical centers, specialty clinics, and outpatient surgery facilities.
Tariffs are impacting the powder absorbable hemostat market by increasing the cost of imported raw materials such as collagen, gelatin, and cellulose, thereby raising production expenses. Surgical powder formulations and combination hemostats are particularly affected, especially in North America and Europe where imports are significant. Some regions may benefit from local manufacturing incentives or tariff exemptions, which encourage domestic production and innovation in bioresorbable hemostat solutions, partially offsetting the negative effects of tariffs.
The powder absorbable hemostat market research report is one of a series of new reports from The Business Research Company that provides powder absorbable hemostat market statistics, including powder absorbable hemostat industry global market size, regional shares, competitors with a powder absorbable hemostat market share, detailed powder absorbable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the powder absorbable hemostat industry. This powder absorbable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The powder absorbable hemostat market size has grown strongly in recent years. It will grow from $2.48 billion in 2025 to $2.66 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing surgical procedures, rising awareness about blood loss management, availability of collagen and gelatin materials, demand for quick hemostasis, adoption of advanced surgical tools.
The powder absorbable hemostat market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to innovations in powder hemostat formulations, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, increasing geriatric population, rising healthcare expenditure. Major trends in the forecast period include minimally invasive surgical techniques, rapid hemostasis solutions, biocompatible & bioresorbable materials, customizable powder hemostat formulations, growth in ambulatory & outpatient surgical procedures.
The growing number of surgeries is expected to drive the expansion of the powder absorbable hemostat market in the coming years. Surgeries are medical procedures that employ manual or instrument-based techniques to treat injuries, manage illnesses, or improve physical function. The increase in surgical procedures is fueled by the rising prevalence of chronic diseases, which often require surgical intervention for effective management. This growing surgical volume creates a higher demand for efficient bleeding control, thereby boosting the use of powder absorbable hemostats. Their rapid and precise hemostatic action is particularly beneficial in delicate or minimally invasive surgeries, enhancing patient outcomes. For example, in March 2023, data from the British Association of Aesthetic Plastic Surgeons, a UK-based surgical body, revealed that 31,057 cosmetic surgeries were performed in the UK in 2022, representing a significant 102% increase compared to the previous year. Consequently, the rising number of surgeries is fueling the growth of the powder absorbable hemostat market.
Key players in the powder absorbable hemostat market are focusing on creating advanced products, such as plant-based polysaccharide absorbable hemostat powders, to improve clotting effectiveness and enhance safety during surgeries. This type of hemostatic powder is derived from purified natural starch and works by rapidly absorbing blood to initiate clot formation. It is fully bioresorbable, eliminating the need for removal after use. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT, a starch-based passive absorbable hemostatic powder, in the United States. Designed for patients with intact coagulation systems, PERCLOT controls mild surgical bleeding by quickly absorbing water to form a gelled adhesive matrix that acts as a mechanical barrier, promoting the buildup of platelets, red blood cells, and coagulation proteins. This product adds to Baxter's hemostat offerings by helping reduce blood transfusions and complications, while also lowering overall healthcare costs.
In April 2025, Olympus Canada Inc., a Canadian medical technology provider, formed a partnership with EndoClot Plus, Inc. to enhance gastrointestinal (GI) care through advanced endoscopic solutions. This collaboration aims to expand Olympus' GI product line by delivering cutting-edge hemostatic technologies that improve clinical outcomes in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) procedures throughout Canada. EndoClot Plus, Inc. is a US-based manufacturer specializing in powder absorbable hemostat systems.
Major companies operating in the powder absorbable hemostat market are Johnson & Johnson, Baxter International, Integra LifeSciences Corporation, Hangzhou Singclean Medical Products Co. Ltd, Gelita Medical GmbH, Algan Grup SaglIk Hizmetleri, Ferrosan Medical Devices, Hemostasis LLC, CuraMedical B.V., BioCer Entwicklungs GmbH, Medcura Inc., Starch Medical Inc., Aegis Lifesciences, Hemostat Medical GmbH, B. Braun Melsungen AG, Pfizer Hospital Products, Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Anika Therapeutics Inc., Teleflex Medical, Ethicon Biosurgery, Z Medica LLC
North America was the largest region in the powder absorbable hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the powder absorbable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the powder absorbable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The powder absorbable hemostat market consists of sales of chitosan-based hemostats, kaolin-based hemostats, and oxidized regenerated cellulose (ORC) powders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Powder Absorbable Hemostat Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses powder absorbable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for powder absorbable hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The powder absorbable hemostat market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.